COLOMA JASON V (Chief Executive Officer) sold 13.4% of their position (34.50K shares) of MAZE THERAPEUTICS, INC. on the open market
Open‑market sale worth $907.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/3/2026ACC: 0001676170-26-000020
DirectorOfficer· Chief Executive Officer
Since Mar 2026
-34.50K
Net shares
Net seller
$907.0K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
50K acquired · 84.50K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−2.59K
Price / share
$26.31
Trade value
$68.21K
% of position
12.5%
9/1/2026
20.74K→18.15K
Common Stock
Indirect
Shares
−31.91K
Price / share
$26.29
Trade value
$838.78K
% of position
12.5%
9/1/2026
255.26K→223.35K
Common Stock
Direct
Shares
+50K
Price / share
—
Trade value
—
% of position
New position
9/1/2026
0.00→50K
Total
Net shares
+15.50K
Net value
-$907K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/1/2026 | S · Sale | −2.59K | $26.31 | $68.21K | 12.5% | 20.74K | 18.15K |
| Common Stock Indirect | 9/1/2026 | S · Sale | −31.91K | $26.29 | $838.78K | 12.5% | 255.26K | 223.35K |
| Common Stock Direct | 9/1/2026 | M · Option Exercise | +50K | — | — | New position | 0.00 | 50K |
| Total | +15.50K | -$907K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
50K shares
Shares
−50K
Strike price
Held after
50K
Exercisable
—
9/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock50K shares | 9/1/2026 | M · Option Exercise | −50K | — | 50K |